We evaluated the effects of acetazolamide on Na'-HCOi cotransport in basolateral membrane vesicles isolated from the rabbit renal cortex. Na' uptake stimulated by an imposed inward HCO3 gradient was not significantly reduced by 1.2 mM acetazolamide, indicating that acetazolamide does not directly inhibit Na'-HCOj cotransport. 4,4'-Diisothiocyanostilbene-2,2'-disulfonate (DIDS)-sensitive Na'-base cotransport was found to be absolutely C02/HCO-dependent. We therefore tested whether acetazolamide-sensitive availability of HCO3 at the basolateral membrane could be rate-limiting for Na'-base cotransport under some conditions. In the presence of a C02/HCO3 buffer system but absence of an initial HCO3 gradient, Na' influx was stimulated fivefold by an outward NHM gradient. This stimulation of Na' influx by an outward NHM gradient was inhibited > 75% by 0.6 mM acetazolamide, suggesting that acetazolamide blocked the ability of the NM gradient to generate an inward HCO3 gradient. In the presence of an inward HCO3 gradient, Na' influx was inhibited > 70%
Introduction membrane (6) (7) (8) (9) (10) . However, recent studies indicate that acetazolamide also inhibits the process of HCO exit across the basolateral membrane of the proximal tubule cell (11, 12) . In the proximal tubule, an electrogenic Na'-HCO-cotransport (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) with a stoichiometry of three bicarbonate per one sodium (16, 23) is the principal pathway for exit of HCO3 across the basolateral membrane. The important question then arises of whether acetazolamide inhibition ofHCO exit results from a direct or indirect interaction with the Na'-HCO cotransport system. We have studied this question using basolateral membrane vesicles isolated from the rabbit renal cortex, which has been a useful experimental model for characterizing the properties of this transport pathway (21) (22) (23) . We find that acetazolamide does not inhibit the Na'-HCO cotransport system directly but rather inhibits indirectly by retarding the generation of HCO, a required substrate for operation of this transport mechanism. This interaction of acetazolamide with the Na+-HC0 cotransport system may be important for explaining the mechanism by which this drug inhibits acid-base transport not only in the proximal tubule but also in other epithelia, such as the cornea and stomach, in which Na'-HCO5 cotransport is a major mechanism for mediating base exit across the plasma membrane (24-26).
Methods
Membrane preparation. Male New Zealand white rabbits were killed by intravenous pentobarbital. Basolateral membrane vesicles were isolated from the renal cortices by differential and Percoll gradient centrifugation, as described previously (21) . The membrane vesicles were suspended in a medium consisting of 250 mM sucrose, 10 mM Hepes titrated to pH 7.6 with tetramethylammonium (TMA)' hydroxide.
The vesicles were then either placed on ice at 0-40C and used for transport studies within 18 h, or frozen and used within I wk ofstorage at -700C. No differences were noted in the properties of the Na+-HCO-cotransport system when fresh and frozen membranes were compared. The purification of the basolateral membrane vesicles relative to the initial homogenate was 10-14-fold based on enrichment in specific activity of Na+,K+-ATPase.
Orientation ofbasolateral membrane vesicles. The specific activity of Na+,K+-ATPase was assayed under several different conditions (Table I ) in order to estimate the relative amounts of the enzyme in right-side-out vesicles, inside-out vesicles and broken membranes (indistinguishable from unsealed or leaky vesicles) (27) . The general procedure for the Na+,K+-ATPase assay was modified from Forbush (28 Therefore, the total Na+,K+-ATPase is the difference between the activity measured in the presence of SDS (a) less that measured in the presence of SDS with ouabain (b). The latter (b) represents the ouabain-insensitive ATPase activity (i.e., Mg-ATPase). Na+,K+-ATPase in right-side-out vesicles requires SDS to provide access of ATP to its site on the internal face of the membrane. Thus, the proportion of rightside-out vesicles is the increment in apparent Na+,K+-ATPase activity resulting from the addition ofSDS (a-c), which was equal to 75% ofthe total Na+,K+-ATPase activity. Na+,K+-ATPase in inside-out vesicles requires SDS to provide access ofouabain to its inhibitory site. Accordingly, the proportion of inside-out vesicles is the decrement in ATPase resulting from the addition of SDS in the presence of ouabain (d-b), which was equal to 19% ofthe total Na+,K+-ATPase activity. Na+,K+-ATPase in broken membranes does not require SDS to provide access of substrates and ouabain to their respective sites. Hence, the proportion of broken or leaky vesicles is the ouabain-sensitive ATPase measured in the absence of SDS (c-d), which was equal to 6% of the total Na+,K+-ATPase activity. 22Na transport measurements. In general, the timed uptake of 22Na by aliquots of membrane vesicle suspension (160-220,ug protein/sample) were assayed in triplicate at room temperature by the rapid filtration technique previously described (21) . The ice-cold medium used to dilute and wash the vesicles at the termination of the period of uptake consisted of 170 mM K gluconate, 10 mM Hepes titrated to pH 7.5 with TMA hydroxide. Each Millipore filter (0.65 Mm, DAWP) was placed in 3 ml Opti-Fluor (Packard Instrument Co., Inc., Downers Grove, IL) and radioactivity assayed by scintillation spectroscopy. The final composition of the experimental media and other details of the protocols are given in the figure legends. The membrane suspension and all experimental media were continuously gassed with 5% C02/95% N2, or 10% CO2/90% N2. All experiments were performed using vesicles treated with valinomycin (0.5 mg/ml) and preequilibrated in media of appropriate composition to ensure that [ 
Results
In the first experiment (Fig. 1) , we tested for a direct effect of acetazolamide on Na' influx stimulated by an inward HCO3 gradient. The inward HCO5 gradient was imposed by setting an inside-acid pH gradient in the presence of a CO2/HCO3 buffer system. Different concentrations of acetazolamide were added to the extravesicular medium at the initiation of the 5-s uptake measurement and were also preincubated with the membrane vesicles for 120 min at room temperature to provide access to the intravesicular space. As illustrated, no significant inhibition resulted from acetazolamide concentrations < 0.6 mM, and maximal inhibition at 1.2 mM drug was only 17%. These results suggest that acetazolamide has little effect as a direct inhibitor of the Na'-HCO-cotransport system in renal basolateral membrane vesicles.
We next considered the possibility that the inhibitory effect of acetazolamide on base exit from the proximal tubule cell as observed in the intact tubule might result from its ability to inhibit the carbonic anhydrase-mediated generation of HCO3 at the basolateral membrane ofthe cell. This would inhibit the process of base exit via the Na'-HCO-cotransporter if base transport via this system were highly HCO--dependent. We therefore evaluated the HCO--dependence of this transport system in basolateral membrane vesicles. Fig. 2 , imposing an inside-acid pH gradient in the absence of CO2/HCO-(center group of three bars) modestly stimulated Na+ influx compared to that measured in the absence of a pH gradient (right). This suggested that Na+-OH- The results of the experiment schematically illustrated in Fig. 3 are'shown in Fig. 4 . As predicted in the preceding paragraph, imposing an outward NHW gradient stimulated Na+ influx greater than fivefold, reflecting the generation of an inward HCO5 gradient. This stimulation of Na+ influx by the outward NHW gradient was minimally inhibited when 0.6 mM acetazolamide was added to the extravesicular medium only, but was inhibited > 75% when 0.6 mM acetazolamide was, in addition, preloaded into the vesicles by preincubation for 120 min. These findings indicate that acetazolamide can indeed interact with the Na'-HCO-cotransport system, in this case causing inhibition of influx by blocking the carbonic anhydrase-mediated generation of an inward HCO-gradient.
Shown in
Although acetazolamide has been most frequently characterized as an inhibitor of acid-base transport mechanisms, one would predict that under certain conditions its effects on HCO5 generation and consumption might actually lead to a stimulation of transport activity. An experiment to test this prediction is schematically illustrated in Fig. 5 acetazolamide should inhibit the collapse ofthe inward HCO3 gradient and thereby release the inhibition of Na+ influx otherwise resulting from imposition of the inward NH4+ gradient. The results of the experiment schematically illustrated in Fig. 5 are shown in Fig. 6 . As predicted in the preceding paragraph, imposing an inward NHWT gradient inhibited Na+ influx > 70%, reflecting the collapse of the inward HCO-gradient.
This inhibition of Na+ influx by the inward NHW gradient was virtually unchanged when 0.6 mM acetazolamide was added to the extravesicular medium only, but was reduced to only 35% when 0.6 mM acetazolamide was, in addition, preloaded into the vesicles by preincubation for 120 min. Thus, in this experiment acetazolamide actually caused stimulation of influx via the Na+-HCO-cotransport system, as it blocked the carbonic anhydrase-mediated collapse of the initially imposed inward HCO-gradient. These findings underscore the indirect nature ofthe interaction of acetazolamide with the Na+-HCO-3 cotransport system, as the drug can cause either inhibition or stimulation depending on the conditions with respect to pH and HCO-gradients.
An important assumption underlying this approach is that the imposed NH+ gradients have no direct effect on Na+ trans- port other than via alterations in the transmembrane pH and HCO-gradient. We tested this assumption in two ways. In the first approach, we evaluated the effects of NHW gradients on Na+ transport in the presence of higher buffer capacity (Table   II ). In Fig. 4 , an outward NHW gradient of 60 mM:6 mM was found to stimulate Na+ uptake fivefold into vesicles preequilibrated with 10 mM Hepes and 28 mM HCO5 at pH 7.5. As shown in Table II , imposing the same outward NHW gradient failed to significantly stimulate Na+ uptake into vesicles pre- The experiments shown in Figs. 4 and 6 were repeated using media of higher buffer capacity. "(NHI4); > (NHWt)O": Uptake of 22Na was assayed as described for Fig. 4 except that the concentrations of Hepes, TMA-OH, and choline-bicarbonate were 52, 26, and 57 mM, respectively. Media were gassed with 90% N2, 10% CO2. "(NH )0 > (NHW)": Uptake of 22Na was assayed as described for Fig. 6 except that the concentrations of TMA-gluconate, Mes, Hepes, and TMA-OH in the preequilibration medium were 160 mM, 64 mM, 52 mM, and 26 mM, respectively; and the concentrations of mannitol, Mes, Hepes, TMA-OH, and choline-bicarbonate in the incubation media were 52, 6, 52, 32, and 57 mM, respectively. Media were gassed with 90% N2, 10% CO2. Each datum represents the mean±SE for three experiments performed in triplicate on different membrane preparations, and is expressed as percentage of the control Na' uptake measured in the absence of NH4 under the same conditions. equilibrated with 52 mM Hepes and 57 mM HCO-at pH 7.5.
Similarly, in Fig. 6 , an inward NHI gradient of 60:0 mM was found to inhibit Na' uptake > 70% into vesicles preequilibrated with -5 mM Hepes and 6.5 mM 2-(N-morpholino)ethanesulfonic acid (Mes) at pH 6.0. As shown in Table II, impos- ing the same inward NM gradient failed to significantly inhibit Na' uptake into vesicles preequilibrated with 52 mM
Hepes and 64 mM Mes at pH 6.0. Thus, the effects of NW gradients on Na' transport were virtually abolished when the intravesicular buffering capacity was increased, strongly arguing against a direct interaction of NW with the Na'-HCO3 cotransport system. Another approach was to use an acetate gradient rather than an NH' gradient to alter the transmembrane pH gradient. The protocol of an experiment to evaluate the effect of an outward acetate gradient on Na+ uptake in the presence of an inward HCO-gradient is schematically illustrated in Fig. 7 . The outward acetate gradient would alkalinize the intravesicular space by consuming internal H+ as undissociated acetic acid diffuses outward down its concentration gradient. This in turn would generate internal OH-, which, in the presence of a CO2/HCO-buffer system, would generate internal HCO-. The resulting collapse of the inward HCO-gradient would then inhibit Na+ influx. If the rate of generation of internal HCO-is carbonic anhydrase-dependent, as shown in Fig. 7 , then inhibition of carbonic anhydrase with acetazolamide should inhibit the collapse of the inward HCO_ gradient and thereby release the inhibition of Na+ influx otherwise resulting from imposition of the outward acetate gradient. The results of the experiment schematically illustrated in Fig. 7 are shown in Fig. 8 . As predicted in the preceding paragraph, imposing an outward acetate gradient inhibited Na+ influx > 80%, reflecting the collapse of the inward HCO3 gradient. This inhibition of Na+ influx by the outward acetate gradient was virtually unchanged when 0.6 mM acetazolamide was added to the extravesicular medium only, but was reduced to only 50% when 0.6 mM acetazolamide was, in addition, preloaded into the vesicles by preincubation for 120 min. Thus, as previously shown in Fig. 6 breakdown of intratubular carbonic acid formed by the titration of filtered HCO-with secreted H+ (6-10). Thus, selective inhibition of externally facing, luminal membrane carbonic anhydrase by use ofa dextran-bound, nonpenetrating carbonic anhydrase inhibitor reduces proximal HCO-reabsorption by almost 80% and produces an acid disequilibrium pH, reflecting the accumulation of intratubular carbonic acid (30) .
However, histochemical and immunocytochemical studies have demonstrated that carbonic anhydrase is localized not only at the luminal membrane but also at the basolateral membrane and in the cytoplasm of the proximal tubule cell (see reference 31 for review). Moreover, carbonic anhydrase activity can be measured in both luminal and basolateral membrane vesicles isolated from the renal cortex (32) . At least three sets of observations suggest that cytoplasmic and/or basolateral membrane carbonic anhydrase plays an important functional role in proximal tubule acid/base transport. First, acetazolamide substantially inhibits acid secretion even when the proximal tubule is microperfused with nonbicarbonate buffers (33). In this circumstance, breakdown of intratubular carbonic acid cannot be rate-limiting for acid secretion, suggesting that the inhibitory effect ofacetazolamide must arise at a site other than the external face of the luminal membrane. Second, in contrast to the acid disequilibrium pH that results from an impermeant carbonic anhydrase inhibitor, a permeant carbonic anhydrase inhibitor inhibits HCO_ reabsorption without generating an acid disequilibrium pH (30) . This indicates that the permeant inhibitor must substantially block the process of H+ secretion across the luminal membrane, thereby preventing the accumulation of intratubular carbonic acid. Third, acetazolamide added to the capillary or peritubular bath inhibits the electrogenic transfer of HCO-across the basolateral membrane (1 1, 12) .
In this study, we examined the effects of acetazolamide on Na'-HCO-cotransport in renal cortical basolateral membrane vesicles. We found no appreciable direct effect of acetazolamide on this transport system. An important observation, however, was that the DIDS-sensitive transport of Na' via this system was absolutely CO2/HCO--dependent. Similar CO2-dependence of basolateral Na'-base cotransport has also been observed in the intact proximal tubule (34) . Based on this observation, we tested whether acetazolamide could indirectly affect the rate of Na'-HCO-cotransport by virtue of its ability to inhibit the carbonic anhydrase-mediated generation or consumption of HCO5 at the basolateral membrane. This was indeed the case, as the drug caused either inhibition or stimulation of Na+-HCO-cotransport depending on the conditions with respect to pH and HCO-gradients.
In our experiments, the effects of acetazolamide on Na+-HCO-cotransport were evident only when the vesicles were preloaded with acetazolamide and not when acetazolamide was present exclusively in the extravesicular medium. Based on the fact that the basolateral membrane vesicle preparation was found to have a predominantly right-side-out orientation, one interpretation of these findings is that the effects of acetazolamide resulted from inhibition of either cytoplasmic carbonic anhydrase trapped within the vesicles or carbonic anhydrase located on the internal surface of the basolateral membrane. However, the lack of effect of extravesicular acetazolamide does not necessarily indicate that there is no carbonic anhydrase present on the external surface of the basolateral membrane of the proximal tubule. Under the conditions of the experiments reported here, the intravesicular volume is < 1% of the extravesicular volume. Accordingly, transmembrane gradients of NHW or acetate would be expected to cause far larger changes in pH and [HCO ] in the intravesicular compartment than in the extravesicular compartment. Thus, our experiments would only have detected effects of carbonic anhydrase within the intravesicular compartment.
Under physiologic conditions, the likely function of carbonic anhydrase at the inner surface of the basolateral membrane is to facilitate the conversion of base from OH-, which cannot be transported via the Na'-HCO-cotransport system, to HCO5, which is readily transported. In addition, any carbonic anhydrase present on the external surface of the basolateral membrane may also play a functional role in facilitating the dissipation of the HCO-accumulated outside the basolateral membrane, particularly ifthe peritubular interstitium is a poorly mixed compartment. By virtue of these actions, carbonic anhydrase would greatly facilitate the exit of base from the proximal tubule cell via the Na'-HCO-cotransport system. Inhibition of this process by acetazolamide would be expected to alkalinize the proximal tubule cell, as has actually been observed (35, 36) . This in turn would result in inhibition of luminal membrane H+ secretion. Thus, the indirect interaction of acetazolamide with the basolateral membrane Na+-HCO-cotransport system may be an important mechanism underlying inhibition of proximal tubule acid secretion by this agent. Similar effects may explain the inhibitory action ofacetazolamide on acid/base transport in other epithelia in which Na+-HCO-cotransport has been described (24-26).
